PREVOC 250mg price in UAE

Overview

Welcome to Dwaey, specifically on PREVOC 250mg Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Ticlopidine HCl.
PREVOC 250mg is available in the market in concentration 250mg and in the form of Tablets/Film-coated.

ADVANCED PHARMACEUTICAL INDUSTRIES CO. LTD. is the producer of PREVOC 250mg and it is imported from JORDAN, The most popular alternatives of PREVOC 250mg are listed downward .

Mode Of Action

Ticlopidine inhibits adenosine diphosphate-mediated platelet aggregation.

Indication

Hereditary hemorrhagic telangiectasia
Intermittent claudication
Ischaemic heart disease

Precaution

Patients with increased risk of bleeding from trauma, surgery or pathological disorder. Moderate to severe renal impairment. May need to stop therapy 10-14 days before elective surgery. Full blood counts should be performed prior to therapy and every 2 wk during the first 3 mth of treatment. Pregnancy. Lactation: not known whether excreted in breast milk, discontinue drug or do not nurse

Side Effects

>10% Diarrhea (12.5%) 1-10% Elevated alkaline phosphatase (7.6%)
Nausea (7%)
Dyspepsia (7%)
Rash (5%)
GI pain (3.7%)
Elevated AST/SGOT (3.1%)
Neutropenia (2.4%)
Purpura (2.2%)
Vomiting (1.9%)
Flatulence (1.5%)
Pruritus (1.3%)
Dizziness (1%)
Abnormal LFTs (1%)
Anorexia (1%) <1% Agranulocytosis
Aplastic anemia
Pancytopenia
TTP Potentially Fatal: Neutropenia
agranulocytosis
thrombotic thrombocytopenic purpura and aplastic anaemia.

Contra indication

Pre-existing or history of blood dyscrasias; haemostatic disorder or active pathological bleeding (eg. bleeding peptic ulcer, intracranial bleeding); severe hepatic dysfunction. Hypersensitivity. Lactation.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Interaction

Reduced clearance with cimetidine; corticosteroid may antagonise effects on bleeding time. Avoid concurrent use with clopidogrel. Potentially Fatal: Risk of haemorrhage increased with NSAIDs and oral anticoagulants; decreased metabolism of theophylline, phenytoin and bupropion.